Alex Sirois

Alex Sirois

Alex is a freelance contributor to InvestorPlace who provides investment insight that is conversational, actionable, and educational. While he writes about all stock classes, his personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks.

Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing. His number one goal in writing for InvestorPlace is to bring value to the reader.

You can follow Alex on LinkedIn.

Recent Articles

6 Potential Bankrupt Companies to Watch Thanks to Pandemic Woes

Bankrupt companies received significant capital influxes this year. There will be more coming. Here are six that could be next on the chopping block.

6 Growth-Bound Artificial Intelligence Stocks to Buy

Artificial intelligence stocks are deeply intertwined with vehicle autonomy. Click here to learn about six that will play a big part therein.

Novavax Is Still Close to Vaccine Leaders in the Covid-19 Race

NVAX stock is goign to be even more interesting in the next two months. Capacity has risen, and study progress has been made.

IBio is Still Sitting in the Starting Gates of the Vaccine Race

IBIO stock still represents hope for a vaccine. But perhaps it may be time to judge it as a pack member rather than an alpha dog.

The TikTok Failure Doesn’t Really Hurt the Case for Microsoft Stock

MSFT stock has shown volatility in recent weeks but the company remains strong. Click to learn why it is fundamentally a buy still.